K-STREET TRACKER
FOLLOW THE MONEY INTO THE SWAMP
Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.
Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies
💸 Top Spending Clients
| # | Client | Filings | Total $ |
|---|---|---|---|
| 1 |  PFIZER INC.PFE | 47 | $46.8M |
| 2 |  GENERAL MOTORS COMPANYGM | 61 | $46.8M |
| 3 |  META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA | 12 | $44.9M |
| 4 | VISA INC.V | 45 | $37.7M |
| 5 |  AMAZON.COM SERVICES LLCAMZN | 36 | $32.8M |
| 6 |  LOCKHEED MARTIN CORPORATIONLMT | 73 | $29.0M |
| 7 |  FEDEX CORPORATIONFDX | 69 | $27.8M |
| 8 |  ELI LILLY AND COMPANYLLY | 56 | $27.1M |
| 9 |  ALTRIA CLIENT SERVICES LLCMO | 142 | $25.2M |
| 10 |  AMGEN INCAMGN | 19 | $24.9M |
| 11 |  COMCAST CORPORATIONCMCSV | 179 | $24.7M |
| 12 |  MERCK & CO INCMRK | 14 | $24.0M |
| 13 |  SOUTHERN COMPANYSO | 53 | $23.9M |
| 14 |  GOOGLE CLIENT SERVICES LLCGOOGL | 79 | $22.6M |
| 15 |  APPLE INCAAPL | 9 | $22.1M |
| 16 |  T-MOBILE USA INC.TMUS | 121 | $21.0M |
| 17 |  UNITEDHEALTH GROUP INCUNH | 19 | $20.4M |
| 18 |  VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ | 40 | $20.1M |
| 19 |  OCCIDENTAL PETROLEUM CORPORATIONOXY | 30 | $19.7M |
| 20 |  MICROSOFT CORPORATIONMSFT | 103 | $18.8M |
| 21 |  QUALCOMM INCORPORATEDQCOM | 40 | $17.2M |
| 22 |  GENERAL DYNAMICS CORPGD | 11 | $17.0M |
| 23 |  BOEING COMPANYBA | 23 | $16.9M |
| 24 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI | 13 | $16.9M |
| 25 |  ORACLE CORPORATIONORCL | 58 | $16.7M |
🎯 Top Lobbied Tickers
| # | Ticker | Filings | Total $ |
|---|---|---|---|
| 1 | META Meta Platforms Inc. | 129 | $50.2M |
| 2 | PFE Pfizer Inc. | 87 | $48.6M |
| 3 | GM General Motors Company | 103 | $48.4M |
| 4 | V Visa Inc. | 46 | $37.7M |
| 5 | AMZN Amazon.com Inc. | 80 | $35.3M |
| 6 | LMT Lockheed Martin Corporation | 88 | $29.4M |
| 7 | FDX FedEx Corporation | 82 | $28.3M |
| 8 | LLY Eli Lilly and Company | 83 | $28.1M |
| 9 | AMGN Amgen Inc. | 95 | $28.0M |
| 10 | MRK Merck & Co. Inc. | 92 | $27.5M |
| 11 | AAPL Apple Inc. | 64 | $26.8M |
| 12 | GOOGL Alphabet Inc. Class A | 123 | $26.6M |
| 13 | MO | 164 | $26.2M |
| 14 | SO Southern Company | 108 | $26.1M |
| 15 | UNH UnitedHealth Group Inc. | 67 | $23.9M |
| 16 | VZ Verizon Communications Inc. | 116 | $23.8M |
| 17 | TMUS | 159 | $22.7M |
| 18 |  CHTR | 137 | $22.6M |
| 19 | GD General Dynamics Corporation | 127 | $22.5M |
| 20 |  TAT&T Inc. | 134 | $21.6M |
| 21 | ORCL Oracle Corporation | 132 | $20.6M |
| 22 | CMCSA Comcast Corporation | 141 | $20.4M |
| 23 | CI The Cigna Group | 64 | $19.9M |
| 24 | OXY Occidental Petroleum Corporation | 36 | $19.9M |
| 25 | MSFT Microsoft Corporation | 122 | $19.2M |
🆕 Filtered Filings · CARDINAL HEALTH INC.
clear filters| Date | Ticker | Client | Registrant | Amount | Issue |
|---|---|---|---|---|---|
| 2026-04-20 | CAH | CARDINAL HEALTH INC. | POWERS PYLES SUTTER & VERVILLE, P.C. | $30K | Health care and FDA/agriculture appropriations. Enteral nutrition. |
| 2026-04-17 | CAH | CARDINAL HEALTH INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $60K | General issues affecting the health care industry such as drug pricing, pharmaceutical drugs, medical devices, workforce shortages, and product shortages. Pharmaceutical tariffs |
| 2026-04-17 | CAH | CARDINAL HEALTH INC. | TWENTY-FIRST CENTURY GROUP, INC. | $24K | Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. H.R. 4121/S. 2256, FY 2026 Agriculture Appropriations; and H.R. 5304/S. 2587, FY 2026 Labor-HHS Appropriations. Tariff-related matters regarding the distribution and sale of pharmaceutical and m |
| 2026-01-20 | CAH | CARDINAL HEALTH INC. | POWERS PYLES SUTTER & VERVILLE, P.C. | $30K | Health care and FDA/agriculture appropriations. Enteral nutrition. |
| 2026-01-19 | CAH | CARDINAL HEALTH INC. | TWENTY-FIRST CENTURY GROUP, INC. | $24K | Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. H.R. 4121/S. 2256, FY 2026 Agriculture Appropriations; and H.R. 5304/S. 2587, FY 2026 Labor-HHS Appropriations. Tariff-related matters regarding the distribution and sale of pharmaceutical and m |
| 2026-01-15 | CAH | CARDINAL HEALTH INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $60K | General issues affecting the health care industry such as drug pricing, pharmaceutical drugs, medical devices, workforce shortages, and product shortages. The Preserving Patient Access to Long-Term Care Pharmacies Act (H.R. 5031 / S. 3159) |
| 2025-10-23 | CAH | CARDINAL HEALTH INC. | CROWELL & MORING LLP | $0 | |
| 2025-10-20 | CAH | CARDINAL HEALTH INC. | POWERS PYLES SUTTER & VERVILLE, P.C. | $0 | health care and FDA/agriculture appropriations |
| 2025-10-20 | CAH | CARDINAL HEALTH INC. | POWERS PYLES SUTTER & VERVILLE, P.C. | $0 | |
| 2025-10-20 | CAH | CARDINAL HEALTH INC. | CROWELL & MORING LLP | $0 | |
| 2025-10-19 | CAH | CARDINAL HEALTH INC. | TWENTY-FIRST CENTURY GROUP, INC. | $24K | Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. H.R. 4121/S. 2256, FY 2026 Agriculture Appropriations; and FY 2026 Labor-HHS Appropriations. Tariff-related matters regarding the distribution and sale of pharmaceutical and medical products and |
| 2025-10-17 | CAH | CARDINAL HEALTH INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $10K | General issues affecting the health care industry such as drug pricing, pharmaceutical drugs, medical devices, workforce shortages, and product shortages. |
| 2025-09-09 | CAH | CARDINAL HEALTH INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $0 | General issues affecting the health care industry such as drug pricing, pharmaceutical drugs, medical devices, workforce shortages, and product shortages. |
| 2025-08-26 | CAH | CARDINAL HEALTH INC. | POWERS PYLES SUTTER & VERVILLE, P.C. | $30K | health care and FDA/agriculture appropriations |
| 2025-08-22 | CAH | CARDINAL HEALTH INC. | POWERS PYLES SUTTER & VERVILLE, P.C. | $0 | Health care and FDA/agriculture appropriations. |
| 2025-07-21 | CAH | CARDINAL HEALTH INC. | CROWELL & MORING LLP | $20K | General health care issues |
| 2025-07-18 | CAH | CARDINAL HEALTH INC. | TWENTY-FIRST CENTURY GROUP, INC. | $24K | Tariff-related matters regarding the distribution and sale of pharmaceutical and medical products and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. H.R. 4121/S. 2256, FY 2026 Agriculture Appropriations; and FY 2026 Labor-HHS Appropriations. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and |
| 2025-04-21 | CAH | CARDINAL HEALTH INC. | TWENTY-FIRST CENTURY GROUP, INC. | $24K | Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. |
| 2025-04-21 | CAH | CARDINAL HEALTH INC. | CROWELL & MORING LLP | $10K | Issues related to pharmaceutical drugs and medical devices Issues related to medical device and pharmaceutical tariffs |
| 2025-01-21 | CAH | CARDINAL HEALTH INC. | TWENTY-FIRST CENTURY GROUP, INC. | $24K | Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; Drug Supply Chain Security Act (DSCSA), and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; Drug Supply Chain Security Act (DSCSA), and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Drug Supply Chain Security Act (DSCSA), and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; drug shortages; Food as Medicine; and the healthcare supply chain; H.R. 9029, FY 2025 LHHS Appropriations. |
| 2025-01-21 | CAH | CARDINAL HEALTH INC. | CROWELL & MORING LLP | $0 | Issues related to pharmaceutical drugs and medical devices |